NTOMBIZODWA SAYI: Open Payments
NPI 1134621683 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 9 payments from 5 companies in 2025. Trend: 2023 $419 · 2024 $1,296 · 2025 $688
Food & beverage: $388Speaker / faculty: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $470 |
| Daiichi Sankyo Inc. | 1 | $124 |
| Syndax Pharmaceuticals, Inc. | 2 | $49 |
| Incyte Corporation | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $21 |
Products named: IMFINZI, DATROWAY, ENHERTU, MONJUVI, Orserdu.
Industry payments across TX — which companies pay providers there.
